SOURCE: AmexDrug Corp.

AmexDrug Corp.

October 13, 2009 06:00 ET

AmexDrug Corp. Shows Continued Growth in Challenging Economy

BEVERLY HILLS, CA--(Marketwire - October 13, 2009) - AmexDrug Corporation (OTCBB: AXRX), a US pharmaceutical and cosmeceutical company, is showing signs of growth despite poor economic conditions. These increases will be seen for the rest of the year, moving strong into 2010.

"We are thriving in the Health Care Industry," said Jack Amin, President and CEO of AmexDrug Corp. "Our vertical company manages, by and large, all aspects of manufacturing, packaging and distribution. We have expanded and operate in all 50 states!"

The significant increase in sales over the past year has boost revenues up 65.7% according to its 2009 Q2 results. Amin has credited much of the success to the last 12 months of marketing and his effective workforce. He expanded the company with an office into Asia Pacific this year.

"We currently have three subsidiaries and a superior manufacturing facility located in California, but we want to expand and grow. We want to acquire companies with whom an incorporation with AmexDrug Corp. will offer a mutual benefit," said Amin.

About AmexDrug Corporation (OTCBB: AXRX):

AmexDrug Corp. is a vertically integrated pharmaceutical and cosmeceutical company. With its subsidiaries BioRx Pharmaceuticals, Dermagen, Inc., and Allied Med, Inc., AmexDrug Corp. develops, manufactures, markets, and distributes private-label over-the-counter pharmaceuticals, innovative skin care products and prescription packaging to the nation's largest wholesalers and distributors. In addition, the company distributes prescription drugs to independent pharmacies. AmexDrug Corp. has an experienced executive team, advanced manufacturing facility and broad distribution network, allowing the company to integrate various phases of operations into one efficient business entity. For more information about AmexDrug Corp., please visit

Safe Harbor Statement:

Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors such as the level of business and consumer spending, economic conditions in the industry and the financial strength of the company's customers and suppliers. The company does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.

Contact Information